The core activity of Lyfjos GmbH is the development, evaluation and commercialization of intellectual property and derived products, particularly in the field of blood diseases. The company focuses on creating cost-effective and robust treatments and diagnostic tools, especially for rare anemias and other blood diseases. Lyfjos works closely with researchers, universities and hospitals to translate scientific findings into practical applications and improve the treatment of patients with rare blood diseases.